Nephros, Inc. (NEPH)

Market Cap	16.24M
Revenue (ttm)	13.55M
Net Income (ttm)	-929,000
Shares Out	10.54M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,722
Open	1.571
Previous Close	1.520
Day's Range	1.530 - 1.571
52-Week Range	1.360 - 4.040
Beta	1.19
Analysts	Buy
Price Target	5.00 (+224.68%)
Earnings Date	Nov 7, 2024

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters th...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 21, 2004
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: NEPH
• Website: https://www.nephros.com

Financial Performance

In 2023, Nephros's revenue was $14.24 million, an increase of 42.74% compared to the previous year's $9.98 million. Losses were -$1.58 million, -78.66% less than in 2022.

Analyst Forecast

According to one analyst, the rating for NEPH stock is "Buy" and the 12-month stock price forecast is $5.0.

Price Target

$5.0

(224.68% upside)

Analyst Consensus: Buy